ResearcherRush University Medical CenterNo recent work listed
Muhammad R. Haque
Matched on ORCID iD 0000-0002-7487-2667; OpenAlex author ID A5055575152. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 2 papers · 2022: 3 papers
Papers 5
- Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Co-author DOI 10.1007/s11010-022-04377-5↗
- Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Co-author DOI 10.1007/s11010-022-04400-9↗
- Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Co-author DOI 10.1038/s41378-022-00370-6↗
- Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/biomedicines9070705↗
- Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer. Co-author DOI 10.3390/cancers13174487↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Faraz Bishehsari · 5 shared papers, 2021–2022 · strength 0.88
- Paper Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. DOI 10.1007/s11010-022-04377-5↗
- Paper Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer … DOI 10.1007/s11010-022-04400-9↗
- Paper Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. DOI 10.1038/s41378-022-00370-6↗
- Usman Barlass · 3 shared papers, 2021–2022 · strength 0.54
- Paper Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. DOI 10.1007/s11010-022-04377-5↗
- Paper Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer … DOI 10.1007/s11010-022-04400-9↗
- Paper Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/biomedicines9070705↗
- Andrew Armstrong · 3 shared papers, 2021–2022 · strength 0.54
- Paper Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. DOI 10.1007/s11010-022-04377-5↗
- Paper Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer … DOI 10.1007/s11010-022-04400-9↗
- Paper Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/biomedicines9070705↗
- Taslim Ahmed Al-Hilal · 1 shared paper, 2021 · strength 0.16
- Ajaypal Singh · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.